Singapore markets closed
Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,560.91 -1,370.72 (-2.21%) CMC Crypto 200
1,263.49 -94.52 (-6.96%)
Collegium Pharmaceutical, Inc. (COLL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:17PM EDT. Market open.
| Previous close | 37.86 |
| Open | 33.26 |
| Bid | 23.97 x 200 |
| Ask | 31.50 x 100 |
| Day's range | 30.47 - 34.00 |
| 52-week range | 20.83 - 40.95 |
| Volume | |
| Avg. volume | 422,145 |
| Market cap | 1.025B |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | 24.30 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet
Key Insights Collegium Pharmaceutical to hold its Annual General Meeting on 16th of May Salary of US$817.0k is part of...
- Zacks
Collegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- Zacks
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of -2.68% and 1.44%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.